Sirtex is a global healthcare company specializing in the development of targeted therapies for cancer treatment. Their primary product, SIR-Spheres, uses microsphere technology to deliver localized radiation therapy to tumors, specifically in liver cancer patients. Sirtex aims to improve clinical outcomes and the quality of life for patients through innovative oncological treatments. The company values collaboration, diversity, and inclusion, fostering a culture that encourages open communication and team-oriented problem-solving. Sirtex is committed to maintaining high standards of safety and regulatory compliance, ensuring that all products meet global healthcare standards. With a focus on professional growth and employee well-being, Sirtex offers a range of flexible work arrangements and support for career development.